U.S. Markets open in 8 hrs 25 mins

Amgen Inc. (AMGN)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
186.32-0.15 (-0.08%)
At close: 4:00PM EDT
People also watch
Full screen
Previous Close186.47
Bid0.00 x 0
Ask0.00 x 0
Day's Range185.81 - 187.44
52 Week Range133.64 - 191.10
Avg. Volume2,828,890
Market Cap135.95B
PE Ratio (TTM)16.97
Earnings DateN/A
Dividend & Yield4.60 (2.45%)
Ex-Dividend Date2017-08-15
1y Target EstN/A
Trade prices are not sourced from all markets
  • American City Business Journals5 hours ago

    Amgen challenge to Genentech $6 billion cancer drug OK'd by FDA

    A "biosimilar" version of the cancer drug Avastin — Genentech Inc.'s best-selling oncology treatment — was approved Thursday by the Food and Drug Administration, potentially crimping the $6 billion franchise of the South San Francisco-based drug maker's Swiss parent. The drug, which Amgen Inc. (AMGN) and partner Allergan plc (AGN) will sell as Mvasi, also is known by the scientific name bevacizumab. The drug regulator's approval allows it to be used to treat metastatic colorectal cancer and types of lung, kidney, cervical and brain cancers.

  • Is Amgen (AMGN) a Great Stock for Value Investors?
    Zacks15 hours ago

    Is Amgen (AMGN) a Great Stock for Value Investors?

    Let's see if Amgen Inc. (AMGN) stock is a good choice for value-oriented investors right now from multiple angles.

  • Forbes17 hours ago

    How This Immigrant Entrepreneur Built A $5 Billion Healthcare Company

    Learn how this immigrant entrepreneur built a $5 billion company from scratch. This is her story.